Krishnendu paul, Politician

Fusion Health Care Pvt Ltd, a leading innovative pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir drug under the brand name XARAVIR, for the treatment of mild to moderate COVID-19 cases."It gives us immense satisfaction to launch 'XARAVIR' as this drug has the potential to save precious lives. We have launched the product at an affordable price and strive to make it available in sufficient quantities to meet high demand for the drug in the Indian market," said Madhu Ramadugu, Managing Director."We have developed a good recognition in the Indian Pharmaceutical industry with frequent launch of innovative products. In June 2019, we have launched SCORBIX (Vitamin C 1.5 g injection) which is prominently used in the treatment of Sepsis backed up by clinical trials and global protocols. In the current pandemic situation, SCORBIX is used in the treatment of COVID patients due to its antiviral mechsms and strong immunity build up. Presently, SCORBIX is widely used in all renowned Hospitals across India," said Krishnendu Paul, General Manager.Fusion Health Care is known for its innovation - with many "First Time in India Products" which include - SCORBIX (Vitamin C 1.5 g Injection), DIFIDOX (Doxycycline Injection 100 mg) the No.1 brand in India predominantly used in treating dengue, malaria and fever of unknown origin, STAPHONEX (Flucloxacillin Injection 1 g/500 mg), ISEP (Isepamicin Injection 200/400 mg) and many more.The company has recently launched an Immunity Booster product under the brand name D'FEND. It consists of Vitamin C 1000 mg plus Zinc 10 mg, available in sugar free orange flavour, in a tube of 20 effervescent tablets.The role and benefits of Vitamin C plus Zinc have been published in many established journals that indicate to improve immunity and avoid Flu.Marking its 13th anniversary, Fusion Health Care inaugurated its R&D Facility in Hyderabad to bring innovative and affordable products for Indian Market.Fusion Health Care has a strong Pan-India presence with a field force of 600 employees and an innovative portfolio of Critical Care and Cardio-Diabetes products.The company also has its own 24-Hour Help line "Fusion Cares" which will enhance the access to its products including XARAVIR (Favipiravir) during this tough times.This story is provided by BusinessWire India. will not be responsible in any way for the content of this article. (/BusinessWire India)( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Narendra Modi

Lok Sabha Election 2024

Heatwave In India

Mumbai Mega Block

Maharashtra Lok Sabha Election

T20 World Cup 2024

Krishnendu PaulFOLLOW

Krishnendu paul, Latest News

National :Assam Rajya Sabha election 2022: Counting of votes to commence shortly

Hours after the Congress lodged a complaint with the Election Commission of India (ECI) citing a violation of rules by the BJP legislators during voting for the Rajya Sabha elections in Assam on Thursday, the counting for the same is going to begin s ...

Politics :Polling officials sought help from my brother, EVM not from my constituency: BJP candidate Krishnendu Paul

Krishnendu Paul, BJP candidate from Assam's Patharkandi, has rejected opposition allegations involving an EVM at Karimganj and said that it belonged to Ratabari constituency and poll officials sought help to transport it due to inclement weather afte ...

Business :Fusion Health Care launches COVID-19 drug Favipiravir and an immunity booster

Fusion Health Care Pvt Ltd, a leading innovative pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir drug under the brand name XARAVIR, for the treatment of mild to moderate COVID-19 cases. ...